A systematic review of randomized controlled trialsof pharmacological therapy in osteoarthritis of the knee, with an emphasis on trial methodology*

https://doi.org/10.1016/S0049-0172(97)80043-1Get rights and content

Abstract

We systematically reviewed randomized controlled trials (RCTs) of pharmacological therapy in knee osteoarthritis (OA), published between 1966 and August 1994. RCTs were identified by MEDLINE, supplemented by a manual search of reference lists. Qualitative assessment of RCTs was performed using Gotzsche's method; design and analysis features were rated on a scale of 0 (worst) to 8 (best). Heller et al's method was used to compare efficacy of nonsteroidal antiinflammatory drugs (NSAIDs) in comparative trials. A total of 80 RCTs were analyzed (45 involved NSAIDs, 3 analgesics, 5 intraarticular [IA] steroids, 9 biological agents, including IA hyaluronic acid, and 18 mixed modalities, including topical capsaicin). The median design and analysis scores for all 80 RCTs were 2 and 5, respectively. NSAIDs were superior to placebo in all short-term trials, but in the 32 comparative NSAID trials, only five (16%) found significant differences in efficacy. Heller et al's method identified differences in 14 NSAID comparisons; etodolac (600 mg/day) was superior in five of its nine comparisons. Indomethacin and aspirin were the most toxic NSAIDs. IA steroids were superior to placebo in short-term efficacy (<1 month). Biological agents were superior to placebo and generally well tolerated over a mean follow-up of 48 weeks. Acetaminophen was superior to placebo and was comparably efficacious to low-dose naproxen and ibuprofen (<2,400 mg/day). The data support the use of acetaminophen, topical capsaicin, IA steroids, IA hyaluronic acid, and NSAIDs in the treatment of patients with knee OA.

References (103)

  • ScottJ.C. et al.

    Arthritic and other musculoskeletal diseases

  • Centers for Disease Control

    Arthritis prevalence and activity limitations-United States, 1990

    MMWR

    (1994)
  • MoralestorresJ. et al.

    Rheumatic and musculoskeletal diseases and impaired quality of life: a challenge for rheumatologists

    J Rheumatol

    (1996)
  • LiangM.H. et al.

    Costs and outcomes in rheumatoid arthritis and osteoarthritis

    Arthritis Rheum

    (1984)
  • LawrenceR.C. et al.

    Estimates of the prevalence of selected arthritis and musculoskeletal diseases in the United States

    J Rheumatol

    (1989)
  • HochbergM.C. et al.

    Guidelines for the medical management of osteoarthritis. Part 2. Osteoarthritis of the knee

    Arthritis Rheum

    (1995)
  • HellerC.A. et al.

    Nonsteroidal anti-inflammatory drugs and aspirin: analyzing the scores

    Pharmacotherapy

    (1985)
  • TelhagH.

    Niflumic acid in osteoarthrosis

    Scand J Rheum

    (1973)
  • CochraneG.

    A double-blind comparison of naproxen with indomethacin in osteoarthritis

    Scand J Rheum

    (1973)
  • SacksS.

    Diclofenac sodium in rheumatoid arthritis and osteoarthritis

    S Afr Med J

    (1974)
  • SolomonL. et al.

    Orudis in the management of osteoarthritis of the knee

    S Afr Med J

    (1974)
  • JoubertP. et al.

    South African multicentre trial with voltaren in osteoarthritis of the knee

    S Afr Med J

    (1974)
  • BarnesC. et al.

    A double-blind comparison of naproxen with indomethacin in osteoarthrosis

    J Clin Pharmacol

    (1975)
  • TanakaS. et al.

    Double-blind study of naproxen in osteoarthritis of the knee joint

    J Rheumarol

    (1976)
  • MullerF. et al.

    A comparison of tolmetn with aspirin in the treatment of osteoarthritis of the knee

    S Aft Med J

    (1977)
  • BlechmanW. et al.

    Naproxen in osteoarthritis

    Ann Rheum Dis

    (1978)
  • ValtonenE.

    Clinical comparison of fenbufen and aspirin in osteoarthritis

    Scand J Rheum

    (1979)
  • SerryM.

    Proquazone in osteoarthritis of the knee: a double-blind, dose comparison trial

    Pharmatherapeutica

    (1980)
  • ShephardN. et al.

    Comparison of tolmetin sodium with indomethacin in osteoarthritis

    The Practioner

    (1981)
  • KogstadO.

    Double blind crossover trial of piroxicam and naproxen in the treatment of osteoarthritis of hip and knee

    Br J Clin Pract

    (1981)
  • ScharfY. et al.

    A comparative study of naproxen with diclofenac sodium in osteoarthritis of the knees

    Rheumarol Rehabil

    (1982)
  • FranchimontP. et al.

    A double-blind crossover study of benoxaprofen and indomethacin in outpatients suffering from osteoarthrosis of the knees

    Eur J Rheumatol Inflamm

    (1982)
  • WheltonJ. et al.

    Fenbufen and placebo treatment in osteoarthritis

    Pharmacology

    (1982)
  • MeuriceJ.

    Treatment of osteoarthritis: a 3-month comparison between tiaprofenic acid and indomethacin

    Curr Med Res Opin

    (1983)
  • RhymerA. et al.

    Osmosin: a multicentre evaluation of a technological advance in the treatment of osteoarthritis

    Curr Med Res Opin

    (1983)
  • LevensteinJ.

    Isoxicam and indomethacin in acute osteoarthritis

    S Afr Med J

    (1985)
  • LeeP. et al.

    The efficacy of diflunisal in osteoarthritis of the knee

    J Rheumatol

    (1985)
  • LewisT. et al.

    Comparison of diflunisal and piroxicam in the management of patients with osteoarthritis

    Clin Ther

    (1986)
  • BostonP. et al.

    Flurbiprofen sustained-release in OA knee

    Br J Clin Pract

    (1988)
  • WilliamsP. et al.

    Etodolac therapy for osteoarthritis: a double-blind, placebo-controlled trial

    Curr Med Res Opin

    (1989)
  • FrietasG.

    A double-blind comparison of etodolac and piroxicam in the treatment of osteoarthritis

    Curr Med Res Opin

    (1990)
  • AtraE. et al.

    Flurbiprofen versus diclofenac for tike treatment of osteoarthritis of the knee

    DICP

    (1990)
  • PaulsenG. et al.

    Efficacy and tolerability comparison of etodolac and piroxicam in the treatment of patients with osteoarthritis of the knee

    Curr Med Res Opin

    (1991)
  • KarbowksiA.

    Double-blind, parallel comparison of etodolac and indomethacin in patients with osteoarthritis of the knee

    Curr Med Res Opin

    (1991)
  • GrisantiA. et al.

    Comparison of etodolac and diclofenac in osteoarthritis of the knee

    Clin Ther

    (1992)
  • DohertyM.

    The efficacy of arthrotec in the treatment of osteoarthritis

    Scand J Rheum

    (1992)
  • KhanF. et al.

    Double-blind comparison of etodolac SR and diclofenac SR in the treatment of patients with degenerative joint disease of the knee

    Curr Med Res Opin

    (1992)
  • MisraN.P.

    A comparative study of flurbiprofen and piroxicam in osteoarthritis

    J Postgrad Med

    (1992)
  • DickW. et al.

    Safety and efficacy of etodolac compared with piroxicam in patients with degenerative joint disease of the knee

    Clin Ther

    (1992)
  • Cited by (127)

    • Systematic review: The safety of intra-articular corticosteroid injection prior to total knee arthroplasty

      2014, Knee
      Citation Excerpt :

      Osteoarthritis is the single most common cause of disability in older adults, with approximately 10% of patients over 55 years of age affected by painful knee osteoarthritis causing mild to moderate disability [1]. Intra-articular corticosteroid injections are often administered for painful arthritic conditions including osteoarthritis and rheumatoid arthritis, an accepted treatment for many decades [2–7]. A survey from the USA has shown that more than 95% of rheumatologists administer intra-articular steroids [8] and injections are also commonly administered by other health care professionals including Orthopaedic surgeons and General Practitioners (GP) [9].

    • SECOT consensus on medial femorotibial osteoarthritis

      2013, Revista Espanola de Cirugia Ortopedica y Traumatologia
    • A review on the effects of glucosamine for knee osteoarthritis based on human and animal studies

      2011, Hong Kong Physiotherapy Journal
      Citation Excerpt :

      Because the common clinical outcome measures of OA are self-reported pain and functional scales, it is possible that gender difference in perception of pain may affect the scores in the outcome measures. Because nonsteroidal anti-inflammatory drugs and analgesics would provide significantly greater pain relief than placebo [31], continuous use of these mediations during the experimental period may mask the efficacy of GlcN. Two of the studies reviewed did not encourage the use of rescue medication [10,32] and hence less than 9% of participants in these studies had consumed rescue medication (Table 2).

    • Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis - meta-analysis

      2011, Osteoarthritis and Cartilage
      Citation Excerpt :

      The placebo effect size in OA trials tends to be large compared to untreated baseline especially in those involving intra-articular injections72. Also, there is theoretical possibility that intra-articular saline could have a therapeutic effect to that may be sustained for 6 months or more73–75. Furthermore, a therapeutic effect of aspiration of synovial fluid could contribute to a response in patients receiving placebo.

    View all citing articles on Scopus
    *

    Supported in part by a contract from the American College of Rheumatology and a grant from the Arthritis Foundation. Dr Towheed is a recipient of a Clinical Research Fellowship Award from the Canadian Arthritis Society and the Medical Research Council of Canada (September 1, 1995 to June 30, 1996).

    View full text